We are thrilled to announce Dr. Jon Williams from AbbVie as our keynote speaker this year! Dr. Williams is a Research Fellow at AbbVie, where he leads the Chemical Biology and Mass Spectrometry Technologies team. He joined AbbVie in 2015 after a substantial career in Discovery Research at GSK in Research Triangle Park, North Carolina, as well as earlier roles at Amylin Pharmaceuticals and Kraft Foods. Jon received his Ph.D from Purdue University in the Cooks research group. While at GSK and AbbVie, he has led the development and implementation of platforms such as open-access LC/MS analysis, high-throughput applications using MALDI-ESI, proteomics, chemoproteomics, and CETSA® to help scientists across therapuetic areas and platform teams answer challenging questions in drug discovery. He is especially interested in applying innovative analytical technologies to connect compound activity with biological mechanisms and accelerate decision-making from early discovery through translational research.
His talk will be titled: Driving drug discovery productivity using novel mass spectrometry workflows
